The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain
Open accessAbstract
Objective To compare the efficacy and safety of SC depot medroxyprogesterone acetate (DMPA-SC 104) with that of leuprolide acetate in treatment of endometriosis.Design Phase 3, multicenter, randomized, evaluator-blinded, comparator-controlled trial.Setting Clinical trial sites in Canada and United States.Patient(s) Two hundred seventy-four women with surgically diagnosed endometriosis.Intervention(s) Intramuscular injections of DMPA-SC (104 mg) or leuprolide acetate (11.25 mg), given every 3 months for 6 months, with 12 months of posttreatment follow-up.Main outcome measure(s) Reduction in five endometriosis symptoms or signs (dysmenorrhea, dyspareunia, pelvic pain, pelvic tenderness, pelvic induration); change in bone mineral density (BMD), hypoestrogenic symptoms, bleeding, and weight.Result(s) The depot medroxyprogesterone acetate given SC was statistically equivalent to leuprolide in reducing four of five endometriosis symptoms or signs at the end of treatment (month 6) and in reducing all five symptoms after 12 months' follow-up (month 18). Patients in the DMPA-SC 104 group showed significantly less BMD loss than did leuprolide patients at month 6, with scores returning to baseline at 12 months' follow-up. No statistically significant differences in median weight changes were observed between groups. Compared with leuprolide, DMPA-SC 104 was associated with fewer hypoestrogenic symptoms but more irregular bleeding.Conclusion(s) Efficacy of DMPA-SC 104 was equivalent to that of leuprolide for reducing endometriosis-associated pain, with less impact on BMD and fewer hypoestrogenic side effects but more bleeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Depot medroxyprogesterone acetate (MPA; 104 mg, subcutaneous injection, every 3 months) has demonstrated an efficacy equivalent to LA, but long-term use of depot MPA preparations is shown to impact adversely on bone mineral density (BMD), while the delay in resumption of ovulation that may follow discontinuation of this therapy is a contraindication to use in women wishing to conceive in the near”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schlaff et al., 2006
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MPA appeared to be more effective than placebo [214] and as effective as danazol [215] and GnRH-agonists [216, 217] in reducing endometriosis-related pain.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [217]
The cited source says what the claim attributes to it.
In the citing paper
“Irregular uterine bleeding is a known adverse effect of treatment with progestins, including depot preparations of MPA, which have been compared in trials against LA (Vercellini et al., 2003;Crosignani et al., 2006;Schlaff et al., 2006).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schlaff et al., 2006
In the citing paper
“In both studies DMPA-SC was statistically equivalent to GnRHa in reducing pain symptoms after 12 months' follow-up.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [51]
In the citing paper
“Patients in the DMPA-SC group showed significantly less BMD loss than did leuprolide patients at month 6.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [51]
In the citing paper
“Progestins were positively associated with HRQoL in women with endometriosis [20,21,23-25,27,29,30].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [25]
In the citing paper
“Six months of GnRHa treatment improved women’s HRQoL even at one year after treatment, according to the SF-36 questionnaire [24-27,29], as well as work-related indexes [18,20].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [25]
In the citing paper
“Moreover, six months of therapy with progestins seemed equivalent to that of GnRHa in improving HRQoL and reducing pain, according to six RCTs [20,23-25,27,29].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [25]
In the citing paper
“Subcutaneous injections of depomedroxyprogesterone acetate (104 mg/0.65 mL) improved all pre-specified scales of the EHP-30 and SF-36 from baseline to the end of the 6-month treatment and even at the 18-month follow-up [24,25].”
From Health-related quality of life in women with endometriosis: a systematic review (2012) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Friedman, A. J., & Hornstein, M. D. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56090-7 · Cited by 47
RetractedDlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279
Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
Hornstein, M. D. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00620-0 · Cited by 244
Progestins for symptomatic endometriosis: a critical analysis of the evidence
Vercellini, P., Cortesi, I., & Crosignani, P. G. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00193-3 · Cited by 229
Contraceptive efficacy and safety of DMPA-SC
Jain, J. K., Jakimiuk, A. J., Bode, F. R., Ross, D., & Kaunitz, A. M. (2004) · Contraception · doi:10.1016/j.contraception.2004.06.011 · Cited by 178
Self-citationSchwallie, P. C., & Assenzo, J. R. (1973) · Fertility and Sterility · doi:10.1016/s0015-0282(16)39669-8 · Cited by 167
Cosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Endometriosis: Treatment Strategies
VALLE, R. F., & Sciarra, J. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.026 · Cited by 151
Westhoff, C. L. (2003) · Contraception · doi:10.1016/s0010-7824(03)00136-7 · Cited by 146
Lockhat, F. B. (2004) · Human Reproduction · doi:10.1093/humrep/deh004 · Cited by 135
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–168 of 168
Geoffron, S., Cohen, J., Sauvan, M., Legendre, G., Wattier, J., Daraï, É., Fernandez, H., & Chabbert‐Buffet, N. (2018) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2018.02.011 · Cited by 7
Guidelines for management of endometriosis
Kim, M.-R., Kim, S. H., Shin, J., Lee, S. R., Lee, J. R., Cho, S., Choi, Y. S., & Lee, B. S. (2011) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2011.54.8.399 · Cited by 7
Allen, C. L., Banerjee, S., Karoshi, M., Humaidan, P., & Tahmasebi, F. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-025-07957-0 · Cited by 6
Safety of current strategies to manage moderate to severe pain in patients with endometriosis
Ferrero, S., Barra, F., Vatteroni, G., Rosato, F. P., Evangelisti, G., Paudice, M., & Vellone, V. G. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2547017 · Cited by 7
Geoffron, S., Legendre, G., Daraï, É., & Chabbert‐Buffet, N. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.005 · Cited by 6
An Atypical Presentation of Vaginal Agenesis
Huguelet, P. S., May, L. T., & Scott, S. M. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.10.005 · Cited by 6
Progestins and combined oral contraceptives in the hormonal treatment of endometriosis – a review
Rojek, K. (2023) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2023.2.21 · Cited by 5
Chronic Abdominal Pain of Gynecologic Causes: Diagnosis and Treatment
Yamamoto, M. P., Carillo, J. F., & Howard, F. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1992-5_10 · Cited by 5
Contraception and gynaecological care
Cameron, S. T. (2009) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.11.003 · Cited by 5
Taylor, R. N., & Lebovic, D. I. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00026-3 · Cited by 6
Progestins for the Treatment of Endometriosis: An Update
Lazzeri, L., Luisi, S. V., & Petraglia, F. (2010) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/228402651000200401 · Cited by 5
DMPA: battered and bruised but still needed and used in the USA
Nelson, A. L. (2010) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.10.60 · Cited by 5
Vargas, M. V., & Huang, K. (2018) · Evidence-based Obstetrics Gynaecology · doi:10.1002/9781119072980.ch8 · Cited by 2
Approaching ovarian endometrioma with medical therapy
Vignali, M., SOLIMA, E., BARBERA, V., BECHERINI, C., & BELLONI, G. M. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.20.04751-6 · Cited by 4
Ferreira, M. B. C., Mitidieri, A. M. D. S., Silva, J. C. R. E., Poli‐Neto, O. B., Nogueira, A. A., & dos Reis, F. J. C. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12340 · Cited by 4
Medical Treatment in Endometriosis
Pourmatroud, E. (2012) · InTech eBooks · doi:10.5772/29932 · Cited by 4
Evidence-based long-term management of endometriosis: Medical therapy and treatment of infertility
Bedaiwy, M. A. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.06.001 · Cited by 4
Horne, A. W., & Critchley, H. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch34 · Cited by 4
Sun, R., Xu, H., Ma, R., Xu, J., Liu, Y. H., & Mao, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1792793 · Cited by 3
Depot Medroxyprogesterone Acetate
McCullough, D. C., Eraso, K. M., & Kaunitz, A. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-46391-5_6 · Cited by 3
Progestin Injectable Contraceptives
Allen, R. H., Cwiak, C. A., & Kaunitz, A. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-20185-6_8 · Cited by 3
Wang, J. K. C., Robinson, C. A., & Burkman, R. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00027-3 · Cited by 3
Brief update on endometriosis treatment
Al‐Jefout, M. (2011) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2011.01.002 · Cited by 3
Pain Associated with Endometriosis: Therapeutic Options
Luciano, D. E., & Luciano, A. A. (2006) · Women s Health · doi:10.2217/17455057.2.4.617 · Cited by 3
Self-citationDiagnosis and treatment of endometriosis
Kim, H., & Cho, S. (2019) · Journal of Korean Medical Association · doi:10.5124/jkma.2019.62.10.513 · Cited by 4
Holt, V. L., Trabert, B. L., & Upson, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00018-2 · Cited by 3
Safety and efficacy of hormonal therapies used to treat endometriosis in women suffering migraine
Perrone, U., Barra, F., Evangelisti, G., Izzotti, A., Gustavino, C., Antonelli, A., Maggiore, U. L. R., & Ferrero, S. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2627190 · Cited by 2
Effect of Medical Therapies for Endometriosis on Bone Health
Desilets, J., Lakabi, R., Olsthoorn, A. V., Matelski, J. J., Walsh, C., Murji, A., & Miazga, E. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006241 · Cited by 3
Endometriosis: Current and Emerging Therapies
Hansen, K. A., & Eyster, K. M. (2011) · Clinical Medicine Reviews in Women s Health · doi:10.4137/cmrwh.s3269 · Cited by 2
Advances in endometriosis treatment
Sheaves, C. (2013) · The Nurse Practitioner · doi:10.1097/01.npr.0000425826.90435.a8 · Cited by 2
Gupta, S., Harlev, A., Agarwal, A. K., Rakhit, M., Ellis-Kahana, J., & Parikh, S. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_10 · Cited by 2
Tratamientos farmacológicos de la endometriosis (a excepción de la adenomiosis)
Azoulay, C., Bardy, C., Lasserre, M., & Brun, J.-L. (2018) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(18)88083-3 · Cited by 2
Medical Management of Pain Associated With Endometriosis
(2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34592-3 · Cited by 1
Pinto, A. F., Temponi, C. S., Veloso, É. L. S., Mesquita, H. O., Agnello, L. L., Pereira, M. S. D. L., Oliveira, M. D. A. S., Assunção, Y. V., Mendonça, I. F., Tavares, . N., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n2p322-334 · Cited by 1
Guideline No. 468: Clinical Management of Endometriosis
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, D. K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103382 · Cited by 3
Dun, E. C., Wieser, F. A., & NEZHAT, C. H. (2013) · Journal of Gynecologic Surgery · doi:10.1089/gyn.2012.0119 · Cited by 1
Injectable Contraception: Current Practices and Future Trends
Wolfe, K., & Cansino, C. D. (2015) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-014-0106-7 · Cited by 1
Rabe, T., Ludwig, M. Z., Merkle, E., Hj, A., Kj, B., Hadji, P., Ao, M., Merki, G., Egarter, C., König, K., et al. (2013) · Journal für Reproduktionsmedizin und Endokrinologie · Cited by 1
Progestogens and Endometriosis
Carp, H., Soriano, D., & Zolti, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-14385-9_9 · Cited by 1
Progestogens and Endometriosis
Zolti, M., & Carp, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-52508-8_9 · Cited by 1
Medical Therapies: Randomized Controlled Trials/Traditional Medical Therapies
JOHNSON, N. P. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch33 · Cited by 1
Endometriosis in the Adolescent Patient
Templeman, C. E. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch54 · Cited by 1
Pain related genes in endometriosis: A meta-analysis
Saxena, M. (2015) · The Sydney eScholarship Repository (The University of Sydney)
Endometriosis en la adolescente
Templeman, C. E. (2009) · Clínicas obstétricas y ginecológicas de Norteamérica
Baker, R. M., & Bunton, P. A. (2007) · Holmes Museum Of Anthropology (Wichita State University)
Nelson, H. D., Nygren, P., Freeman, M., & Chan, B. K. S. (2007)
GnRH agonist therapy and the use of sex steroid add-back: improving the product
Olive, D. L. (2011) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.11.58
Use of Depot Medroxyprogesterone Acetate in Current Gynecologic Practice
Nezworski, L., & Murray, S. C. (2010) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000369796.69781.0c
Medical treatment options for endometriosis
MAHUTTE, N. G. (2006) · CRC Press eBooks · doi:10.3109/9781420042726-9
Консенсус по ведению эндометриоза
Johnson, N. P., & Hummelshøj, L. (2013) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2013.12.66-88
Dienogest - The Millennium Molecule!!
Venkatesh, S. (2017) · Open Access Journal of Gynecology · doi:10.23880/oajg-16000141
Manage endometriosis-related pain with hormonal suppression therapies
Writers, A. M. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00601-3
Dienogest-The Millennium Molecule!!
Khan, R. N. (2018) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2018.13.555860
Medical Management of Endometriosis in Adolescents
Perez-Milicua, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-52984-0_39
Jain, S., & Mani, P. (2021) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20210295
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00014-5
Chapitre 3 : Prise en charge médicale de la douleur associée à l'endométriose
Author, N. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.02.131
Pharmacotherapy is a viable option in the treatment of women with endometriosis
&NA; (2009) · Drugs & Therapy Perspectives · doi:10.2165/11204040-000000000-00000
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_12
Hormonal Therapies before In-Vitro Fertilization in Women with Endometriosis
Naem, A., & Laganà, A. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-50662-8_14
Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects
Lin, Y., & Wang, C. C. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_30
Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, D. K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103383
Simhachalam, P., & Sabithakala, T. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70513
Bandini, V., Whitaker, L. H. R., Vincent, K., Salmeri, N., Mawson, R. L., Vercellini, P., & Horne, A. W. (2026) · medRxiv · doi:10.64898/2026.08.26.26361442
The role of dienogest and other progestogens in the management of endometriosis-related pain
Perrone, U., Ferrero, S., Antonelli, A., Izzotti, A., Anatrà, M., & Barra, F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27757-3.00009-2
Tamayo‐Sarver, J. H., & Cydulka, R. K. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544835.029
Using Contraceptives for Gynecologic Conditions
Kattan, D. R., & Burkman, R. T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1233-9_13
Metadata
- Authors
- Schlaff, W. D., Carson, S. A., Luciano, A., Ross, D., & Bergqvist, A.
- Affiliations
- University of Colorado Health (US)
- Baylor College of Medicine (US)
- University of Connecticut (US)
- Pfizer (United States) (US)
- Karolinska Institutet (SE)
- Corresponding author
- Schlaff, William D.
- ORCID
- Luciano, Anthony
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 85
- Issue
- 2
- Pages
- 314-325
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2017780870
- Semantic Scholar
- e24478c88204964afa49b33817b516679f38a0a8
- Cited by
- 168
- References
- 28
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 9 · 2018: 11 · 2017: 8 · 2016: 4 · 2015: 14 · 2014: 7 · 2013: 13 · 2012: 11
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- endometriosis, endometriosis-associated pain, depot medroxyprogesterone acetate, leuprolide, GnRH agonist, GnRH antagonist, subcutaneous injection, bone mineral density, dysmenorrhea, dyspareunia, pelvic pain, irregular bleeding, weight change
- MeSH terms
- Adult, Delayed-Action Preparations, Endometriosis, Estrogens, Female, Flushing, Humans, Injections, Subcutaneous, Pain, Palliative Care, Quality of Life, Uterine Hemorrhage, Bone Density, Single-Blind Method, Leuprolide, Treatment Outcome, Medroxyprogesterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
